Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,053,626,340
+$790,492,094 QoQ
Shares Held
3,379,627
-4.7% QoQ
Ownership
0.359%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#39
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 4%
None 78%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$5,670,016
PutShares
6,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $18,000,750,668 across 17 Drug Manufacturers - General names. LLY ranks #1 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,379,627 | $4,053,626,340 | |
| 2 | JNJ |
Johnson & Johnson
|
15,661,323 | $3,977,506,192 | |
| 3 | ABBV |
AbbVie Inc.
|
10,772,949 | $2,710,904,874 | |
| 4 | AZN |
Astrazeneca PLC
|
12,640,672 | $2,396,924,218 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,964,180 | $1,537,397,125 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,269,170 | $918,386,928 | |
| 7 | AMGN |
Amgen Inc
|
2,355,705 | $853,047,884 | |
| 8 | PFE |
Pfizer Inc
|
31,492,018 | $758,327,787 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,053,626,340 | 3,379,627 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,263,134,246 | 3,547,772 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $4,091,991,705 | 3,807,637 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,501,236,080 | 3,278,160 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,730,282,768 | 3,502,473 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,893,598,801 | 3,503,528 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,335,793,308 | 3,025,639 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $2,884,625,063 | 3,256,005 | Shares | Other | 2025-06-26 | |
| 2024-09-30 | $5,670,016 | 6,400 | Put | Defined | 2025-06-26 | |
| 2024-06-30 | $2,783,339,109 | 3,074,222 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $2,441,629,008 | 3,138,502 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $1,643,706,151 | 2,819,780 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,450,685,531 | 2,700,809 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $1,371,930,167 | 2,925,349 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $974,574,096 | 2,837,849 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $993,696,795 | 2,716,206 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $926,283,923 | 2,864,648 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $836,595,746 | 2,580,254 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $723,772,674 | 2,527,404 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $970,786,783 | 3,514,542 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $708,063,807 | 3,064,548 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $592,356,684 | 2,580,850 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $441,654,616 | 2,364,065 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $344,169,694 | 2,038,437 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $316,830,434 | 2,140,457 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $368,126,193 | 2,242,211 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $264,283,924 | 1,905,161 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||